AstraZeneca PLC
11064,00
24-января-25 11:29:50
15 мин. задержка
Акции
0,00
0,00%
Сегодняшний диапазон
11024,00 - 11140,00
ISIN
N/A
Источник
Cboe
- Котировки
- Графики
Новости
- Статистика
-
Is Now the Right Time to Buy AstraZeneca Stock?
10 дек 2023 07:46:15 Источник NASDAQ US Markets
-
Absci (ABSI) Up on AstraZeneca Deal to Design New Cancer Therapy
05 дек 2023 09:27:21 Источник NASDAQ Stocks
-
Absci, AstraZeneca Join To Deliver AI-designed Antibody Against Oncology Target
04 дек 2023 08:12:31 Источник NASDAQ US Markets
-
AstraZeneca To Discontine STABILIZE-CKD, DIALIZE-Outcomes Trials Under CRYSTALIZE Programme
01 дек 2023 02:39:09 Источник NASDAQ US Markets
-
AstraZeneca Launches Evinova Healthtech Business
20 ноя 2023 09:21:15 Источник NASDAQ US Markets
-
Pharma Stock Roundup: FDA Okays AZN's Capivasertib & MRK's Keytruda Expanded Use
17 ноя 2023 09:20:24 Источник NASDAQ Stocks
-
AstraZeneca: Truqap Plus Faslodex Approved In US For HR+ Breast Cancer
17 ноя 2023 03:04:07 Источник NASDAQ US Markets
-
Interesting AZN Put And Call Options For July 2024
16 ноя 2023 11:57:01 Источник NASDAQ Stocks
-
AstraZeneca : Phase III Trial Of Imfinzi + Chemoradiotherapy In Lung Cancer Fails To Meet Main Goal
14 ноя 2023 03:55:47 Источник NASDAQ US Markets
-
AstraZeneca (AZN) Beats on Q3 Earnings & Sales, Ups 2023 View
10 ноя 2023 09:14:44 Источник NASDAQ Stocks
-
AstraZeneca Plc (AZN) Q3 2023 Earnings Call Transcript
09 ноя 2023 18:26:41 Источник NASDAQ US Markets
-
AstraZeneca Paying Up To $2 Billion For Experimental Obesity Pill—As Weight Loss Drug Market Grows
09 ноя 2023 09:57:51 Источник Forbes - World
-
09 ноя 2023 06:19:20 Источник MarketWatch
-
09 ноя 2023 05:10:57 Источник MarketWatch
-
AstraZeneca Reaches Obesity Drug Deal; Imfinzi Combination Meets Main Goal In Liver Cancer Trial
09 ноя 2023 03:55:26 Источник NASDAQ US Markets
-
AstraZeneca Q3 Pre-tax Profit Climbs; Lifts FY Outlook
09 ноя 2023 03:28:56 Источник NASDAQ US Markets
-
US FTC disputes listing for more than 100 patents in FDA Orange Book
07 ноя 2023 13:01:35 Источник NASDAQ US Markets
-
AstraZeneca (AZN) to Report Q3 Earnings: What's in the Cards?
06 ноя 2023 14:44:08 Источник NASDAQ Stocks
-
AstraZeneca : Canada Approves Ultomiris For Adults With Neuromyelitis Optica Spectrum Disorder
01 ноя 2023 07:46:39 Источник NASDAQ US Markets
-
Cellectis Announces Collaboration Agreement With AstraZeneca; To Receive Up To $245 Mln
01 ноя 2023 05:05:04 Источник NASDAQ US Markets